For starters, they should use Purdue Pharma’s billions to make Narcan universally accessible.

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the first 10 patients.

MEI Pharma, Inc. (NASDAQ:MEIP) stock is trading higher on Friday, with a session volume of 35.64 million compared to the average volume of 29.8K, as per data from Benzinga Pro.

Merck is paying about $10 billion for Verona Pharma, expanding its respiratory disease drug portfolio.

Alaska is set to receive up to $12.2 million over the next 15 years after signing onto a settlement with Purdue Pharma and the Sackler family The Sacklers’ former company, Purdue Pharma, made ...

Rhythm Pharma (RYTM) stock gains as the company's experimental therapy bivamelagon shows promise in Phase 2 trial for rare acquired hypothalamic obesity. Read more here.

VRNA stock has surged after Merck’s $10 billion merger acquisition. Here’s how you should play the stock.

Get the latest stock analysis from Benzinga? This article Why Is Recursion Pharma Stock Surging On Monday? originally appeared on Benzinga.com ...

Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.